Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 16, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was driving topline growth through category adjacencies [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Bath & Body Works, Inc. securities for the period between June 4, 2024, and November 19, 2025, due to alleged misleading statements made by the company regarding its business strategy and financial performance [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Bath & Body Works made materially false and misleading statements about its growth strategy, which failed to deliver the expected results [5]. - The lawsuit alleges that the company's reliance on brand collaborations to mask weak financial results led to a failure to meet previously issued financial guidance [5]. - Investors are encouraged to join the class action to seek compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has a history of significant recoveries for investors, including over $438 million secured in 2019 alone [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works, Inc. due to alleged violations of federal securities laws, encouraging affected investors to contact them for legal options [2][4]. Financial Performance - Bath & Body Works reported a disappointing third quarter for 2025, with a 1% year-over-year decline in revenue, missing prior guidance of 1-3% growth, and a 26% drop in net income to $77 million [5]. - The company significantly reduced its full-year earnings per diluted share guidance from a range of $3.28 to $3.53 to "at least $2.83" [5]. Strategic Issues - The complaint alleges that the company's strategy of pursuing "adjacencies, collaborations and promotions" failed to grow the customer base and did not deliver the expected growth in net sales [4]. - The company admitted that its previous strategy led to reduced investment in core categories and an overreliance on promotions to mask weak financial results [5]. Stock Market Reaction - Following the disappointing financial disclosures, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [6].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Bath & Body Works, Inc. for alleged material misstatements and omissions during the class period from June 4, 2024, to November 19, 2025, affecting investors who purchased or acquired the company's securities [1][6]. Summary by Relevant Sections Allegations - The complaint claims that Bath & Body Works made materially false and misleading statements and failed to disclose adverse facts about its business and operations [2]. - Specific allegations include the failure of the company's strategy of pursuing "adjacencies, collaborations and promotions" to grow its customer base and net sales [2]. - It is alleged that the company relied on brand collaborations to mask weak financial results and was unlikely to meet its previously issued financial guidance [2]. Legal Process - Investors affected by the alleged fraud can seek to be appointed as lead plaintiffs by March 13, 2026, through Kessler Topaz Meltzer & Check, LLP or other counsel [3]. - The lead plaintiff will represent the class in directing the litigation and selecting counsel, with the ability to share in any recovery not affected by the decision to serve as lead plaintiff [3]. Firm Information - Kessler Topaz Meltzer & Check, LLP is a prominent U.S. law firm specializing in securities-fraud class actions and investor protection, representing both individual and institutional investors [5][7]. - The firm has a history of leading significant recoveries in securities litigation and has received numerous accolades for its work [7].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - Following the release of Q3 2025 financial results on November 20, 2025, the company announced further cuts to its full-year guidance and acknowledged that its strategy of pursuing adjacencies had not grown its total customer base, resulting in a stock price decline of $5.22, or 24.8%, from $21.04 to $15.82 per share [7]. Legal Context - Investors have until March 16, 2026, to request to be appointed to lead the class action case, which is pending in the U.S. District Court for the Southern District of Ohio, under the caption Lingam v. Bath & Body Works, Inc., et al. [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Bath & Body Works securities [3].

Core Viewpoint - A class action has been filed against Bath & Body Works, Inc. for allegedly misleading investors regarding its business strategy and financial performance [1][2]. Allegations - The complaint alleges that Bath & Body Works did not disclose that its strategy of pursuing "adjacencies, collaborations and promotions" was failing to grow the customer base and was not delivering the expected growth in net sales [2]. - It is claimed that the company relied on brand collaborations to mask weak financial results as its strategy faltered [2]. - The company is accused of being unlikely to meet its previously issued financial guidance due to these issues [2]. Financial Performance - On November 20, 2025, Bath & Body Works reported disappointing third quarter results, with revenue declining by 1% year over year, missing the guidance of 1-3% growth [3]. - Net income fell by 26% to $77 million, and the company reduced its full-year guidance for net sales and earnings per diluted share from $3.28 to "at least $2.83" [3]. - The company acknowledged that its previous strategy had not grown the total customer base and admitted to an over-reliance on promotions to drive growth [3]. Stock Market Reaction - Following the announcement of the disappointing results and new business strategy, Bath & Body Works' stock price dropped by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [4]. Class Action Participation - Shareholders may be eligible to participate in the class action against Bath & Body Works, with a deadline for lead plaintiff submissions set for March 16, 2026 [4].

New York, New York--(Newsfile Corp. - January 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Bath & Body Works, Inc. (NYSE: BBWI) securities between June 4, 2024 and November 19, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 16, 2026.SO WHAT: If you purchased Bath & Body Works securities during ...

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Bath & Body Works, Inc. securities for the period between June 4, 2024, and November 19, 2025, due to alleged misleading statements and failure to disclose critical information regarding the company's financial performance and strategies [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Bath & Body Works made materially false and misleading statements about its business strategies and financial guidance, which led to investor damages when the true financial situation was revealed [5]. - The lawsuit alleges that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected net sales growth [5]. - It is claimed that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results, ultimately leading to a failure to meet previously issued financial guidance [5]. Group 2: Participation Information - Investors who purchased Bath & Body Works securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by March 16, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Bath & Body Works, Inc. is facing a class action lawsuit due to significant declines in financial performance and misleading statements regarding its business strategy during the class period from June 4, 2024, to November 19, 2025 [1][7]. Financial Performance - On August 28, 2025, Bath & Body Works reported Q2 2025 earnings per diluted share of $0.30, a decline of 55.8% year over year, and net income of $64 million, down 57.9% year over year [3]. - The company cut its full-year guidance for earnings per diluted share by $0.03, adjusting it to a range of $3.28 to $3.53 [3]. - On November 20, 2025, the company reported Q3 2025 revenue declined by 1% year over year, missing guidance of 1-3% growth, and net income fell 26% to $77 million [5]. - The full-year guidance for net sales was slashed from a previously positive 1.5%-2.7% to a negative "high single digits," and expected earnings per diluted share were reduced to "at least $2.83" [5]. Stock Performance - Following the Q2 2025 results announcement, Bath & Body Works' stock price fell by $2.18, or 6.9%, closing at $29.36 per share on August 28, 2025 [4]. - After the Q3 2025 results, the stock price dropped by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [6]. Lawsuit Details - The class action lawsuit alleges that the company made materially false and misleading statements and failed to disclose adverse facts about its business and operations [7]. - Specific allegations include the failure of the company's strategy of "adjacencies, collaborations and promotions" to grow the customer base and the reliance on brand collaborations to mask weak financial results [7]. - The lawsuit claims that the company was unlikely to meet its previously issued financial guidance due to these issues [7]. Participation in the Lawsuit - Investors who purchased Bath & Body Works securities during the class period can file a lead plaintiff motion by March 16, 2026, if they meet certain legal requirements [8].

CoreWeave, Inc. (NASDAQ: CRWV) - The class action lawsuit alleges that during the class period from March 28, 2025, to December 15, 2025, defendants made materially false and misleading statements regarding the company's business and operations [2] - Specifically, it is claimed that defendants overstated CoreWeave's ability to meet customer demand and understated the risks associated with reliance on a single third-party data center supplier [2] - The lawsuit suggests that these misrepresentations were likely to have a material negative impact on the company's revenue, rendering the defendants' positive statements misleading [2] Bath & Body Works, Inc. (NYSE: BBWI) - The class action lawsuit covers the period from June 4, 2024, to November 19, 2025, alleging that defendants made materially false and misleading statements about the company's growth strategies [3] - It is claimed that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected net sales growth [3] - The lawsuit indicates that as the strategy faltered, the company relied on brand collaborations to mask weak financial results, leading to a failure to meet previously issued financial guidance [3] Smart Digital Group Limited (NASDAQ: SDM) - The class action lawsuit pertains to the period from May 5, 2025, to September 26, 2025, alleging that defendants made materially false and misleading statements regarding market manipulation and fraudulent promotion schemes [4] - It is claimed that insiders used offshore accounts to facilitate coordinated share dumping during a price inflation campaign, which was not disclosed to investors [4] - The lawsuit highlights that the company's public statements omitted risks related to fraudulent trading and market manipulation, which could lead to a suspension of trading by regulatory bodies [4]